The Annual American Society of Clinical Oncology (ASCO) meeting will be discussing several new drugs in development. We have been investigating targeted therapies for many years, several with significant promise. These therapies work on a specific pathway that either speeds up cell division or lengthens the tumor cell survival.
Although we have had significant improvements in outcomes for our patients with these drugs, there are...